PTX3 and stroke disorder: Additionally, our PTX3 siRNA approach worked in the mouse model of white matter stroke (Figure 2A), and importantly, mice that received PTX3 siRNA on day 0 showed exacerbated myelin damage/loss on day 3 after stroke compared to mice with control siRNA injection (Figure 2B).